Tapio Juhani Koivu
Director Técnico/Científico/I+D en University of Helsinki .
Perfil
Tapio Juhani Koivu is a Research Director at the University of Helsinki.
He previously worked as a Director at Zora Biosciences Oy and Plexpress Oy.
He also served as the Executive Vice President-Technical Research Center at Teknologian Tutkimuskeskus VTT Oy.
Koivu holds a doctorate from the University of Tampere and a graduate degree from Aalto University.
Cargos activos de Tapio Juhani Koivu
Empresas | Cargo | Inicio |
---|---|---|
University of Helsinki | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Tapio Juhani Koivu.
Empresas | Cargo | Fin |
---|---|---|
Teknologian Tutkimuskeskus VTT Oy
Teknologian Tutkimuskeskus VTT Oy Miscellaneous Commercial ServicesCommercial Services Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland. | Corporate Officer/Principal | - |
Plexpress Oy
Plexpress Oy Pharmaceuticals: GenericHealth Technology Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research. | Director/Miembro de la Junta | - |
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Director/Miembro de la Junta | - |
Formación de Tapio Juhani Koivu.
University of Tampere | Doctorate Degree |
Aalto University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Teknologian Tutkimuskeskus VTT Oy
Teknologian Tutkimuskeskus VTT Oy Miscellaneous Commercial ServicesCommercial Services Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland. | Commercial Services |
Plexpress Oy
Plexpress Oy Pharmaceuticals: GenericHealth Technology Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research. | Health Technology |
- Bolsa de valores
- Insiders
- Tapio Juhani Koivu